Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
10/2007
10/18/2007WO2007116687A1 Heterocyclic compound and luminescence method
10/18/2007US20070244068 2',3'-O-methylenestyryl-5'-alpha-(carboxymethylenephosphono)-N6-ethylaminocarbonyl-adenosine phosphate; modified mononucleoside phosphate by attaching degradation-resistant substituent on terminal phosphate; increase rate & total amount of mucin secretion; epithelial tissue, platelet aggregation diseases
10/18/2007US20070244053 Use of a CD40:CD154 binding interruptor to prevent counter-adaptive immune responses, particularly graft rejection
10/18/2007US20070243565 Luminescence resonance energy transfer (lret) assays for clostridial toxin activity
10/18/2007US20070240728 Reducing Levels of Nicotinic Alkaloids in Plants
10/18/2007CA2640463A1 Preparation of gemcitabine
10/17/2007EP1845102A1 Novel pyrimidine nucleoside compound or its salt
10/17/2007EP1844161A2 Dark quenchers, probes and other conjugates incorporating the same, their use
10/17/2007EP1844063A1 Purine nucleoside analogs
10/17/2007EP1844062A2 Inhibitors of dna methyltransferase
10/17/2007EP1446413A4 Synthesis of 2-aralkoxy adenosines and 2-alkoxyadenosines
10/17/2007CN101054398A Method of synthesizing 2-deoxy-5-iodo-beta-uridine
10/17/2007CN100343268C Beta -2'-or 3'-halonucleosides
10/16/2007US7282581 Complexing with label; immobilization; genetic engineering
10/16/2007US7282361 Treating mammalian tissue with a lysis buffer of proteinase K to obtain a lysate, binding genomic DNA to magnetic particles in the presence of the lysate, and disassociating the DNA from the magnetic particles
10/16/2007US7282333 Methods and compositions for nucleic acid analysis
10/16/2007US7282327 Pyrimidine base containing compound suitable for enzymatic attachment to a nucleic acid, to provide a mechanism of nucleic acid detection
10/16/2007CA2414018C 2-aminocarbonyl-9h-purine derivatives
10/16/2007CA2289585C Novel imaging agents and methods for the preparation and use thereof
10/11/2007WO2007113538A1 Substituted adenines and the uses thereof
10/11/2007WO2007112473A1 Purification of a difluoronucleoside anomer using aqueous acid solution
10/11/2007WO2007092213A3 Inhibitors of e1 activating enzyme
10/11/2007US20070238694 Purine compounds and methods of use thereof
10/11/2007US20070238684 For an improved in vitro and in vivo transformation of particular cells, for example for somatic gene therapy; diagnosis, increased infectivity for cells of low susceptibility, such as haematopoietic cells
10/11/2007US20070237757 Contact tumor cell expressing matrix metalloproteinase 1 with siRNA that has a sequence complementary to part of a matrix metalloproteinase 1 nucleic acid sequence specifically inhibiting synthesis or expression; cancer
10/10/2007EP1842923A1 Methanesulfonylaminoindole derivatives and labeled oligonucleotide probes containing them.
10/10/2007EP1842841A1 Process for production of fluoro derivative
10/09/2007US7279563 Compounds for protecting hydroxyls and methods for their use
10/09/2007US7279482 Such as 6-(2-hydroxy-3-chloroxybenzylamino)purine, 6-(2-hydroxy-4-chlorobenzylamino)purine; agriculture; cloning; immunostimulation
10/09/2007US7279465 Use of amphiphilic nucleoside phosphonoformic acid derivatives for the treatment of viral infectious diseases
10/04/2007WO2007112348A2 Prodrug composition
10/04/2007WO2007112263A2 Monomer compositions for the synthesis of rna, methods of synthesis, and methods of deprotection
10/04/2007WO2007111954A2 Purine compounds and methods of use thereof
10/04/2007WO2007054100A3 Lna nucleoside phosphoramidates
10/04/2007WO2007053702A8 Synthesis of four color 3'-o-allyl modified photocleavable fluorescent nucleotides and related methods
10/04/2007WO2007041342A3 Labeled nucleotide analogs and uses therefor
10/04/2007WO2007035678A3 Methods of identifying agents having antiangiogenic activity
10/04/2007WO2007008471A3 Photolabile system with instantaneous fluorescence reporting function
10/04/2007US20070232798 Process For The Synthesis Of 2'-O-Substituted Pyrimidines And Oligomeric Compounds Therefrom
10/04/2007US20070232562 Antiviral nucleosides
10/04/2007US20070232560 Treatment of skin with adenosine or adenosine analog
10/04/2007US20070232559 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
10/04/2007US20070232521 that can trap isotopic fluorine so that when the biological molecule accumulates in the desired type of cell, the isotopic fluorine is imaged by PET scan
10/04/2007CA2645859A1 2'-fluoronucleoside phosphonates as antiviral agents
10/04/2007CA2643503A1 Purine compounds and methods of use thereof
10/03/2007EP1766006A4 Mucin3 egf-like domains
10/03/2007EP1590475A4 Terminal-phosphate-labeled nucleotides and methods of use
10/03/2007CN101048423A Phosphoramidite compound and method for producing oligo-rna
10/02/2007US7276595 DNA sequence encoding a retinoic acid regulated protein
10/02/2007US7276592 Nucleotide analogs with six-membered rings
10/02/2007US7276475 Remodeling and glycoconjugation of peptides
10/02/2007US7276248 Conjugate having a cleavable linkage for use in a liposome
10/02/2007US7276228 Methods for treating hematological disorders through inhibition of DNA methylation and histone deacetylase
10/02/2007CA2412564C Purine derivatives
10/02/2007CA2330756C Indole derivatives and their use for the treatment of malignant and other diseases based on pathological cell proliferation
10/02/2007CA2262618C Novel boronic acid-containing nucleic acids and their use as diagnostic agents
09/2007
09/27/2007WO2007107598A1 Phosphorylated a2a receptor agonists
09/27/2007US20070225485 Foldable polymers as probes
09/27/2007US20070225249 2'-Fluoronucleoside phosphonates as antiviral agents
09/27/2007US20070225247 (1-{9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide; stable under relative humidity stress
09/27/2007US20070225246 O-acetyl-ADP-ribose non-hydrolyzable analogs
09/27/2007US20070224210 Immunostimulatory nucleic acids
09/26/2007EP1554298A4 Process for the preparation of 9-beta-anomeric nucleoside analogs
09/26/2007EP1140104B1 Treatment of alzheimer's disease by increasing cytidine levels in vivo
09/26/2007CN101044151A Antiviral 4'-azido-nucleosides
09/26/2007CN101044150A Bioreductively-activated prodrugs
09/26/2007CN101043893A Fluorinated pyrrolo[2,3-d]pyrimidine nucleosides for the treatment of rna-dependent rna viral infection
09/25/2007US7273600 unit dose comprises a sufficient amount for in vivo diagnostic imaging of a 2'-deoxy-2'-[18F]- or a 3'-deoxy-3'-[18F]-labeled purine analog for being detected in vivo
09/25/2007CA2245570C Natamycin recovery
09/25/2007CA2204160C Treatment of urogenital cancer with boron neutron capture therapy
09/20/2007WO2007104242A1 Compounds capable of inhibiting zinc ion metalloproteinases
09/20/2007US20070218073 Antigenic composition
09/20/2007CA2643748A1 Process for preparing l-nucleic acid derivatives and intermediates thereof
09/19/2007EP1834645A1 Autoinducer synthase modulating compounds and uses therefor
09/19/2007EP1655301A4 Cyclic bioisosters of purine system derivatives and a pharmaceutical composition based thereon
09/19/2007EP1563089A4 Solid phase based nucleic acid assays combining high affinity and high specificity
09/19/2007EP0977767B1 Aminooxy-modified oligonucleotides
09/18/2007US7271258 Methods of synthesizing oligonucleotides using carbonate protecting groups and alpha-effect nucleophile deprotection
09/18/2007US7271157 Contacting (4S,2R,3R,5R)-2-(6-chloropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol with a protected (2-hydroxy) cyclopentylamine compound having a protecting group on the 2-hydroxy moiety;contacting=with thionyl chloride in the presence of a second base;contacting with base, removing protecting group
09/18/2007US7270956 sample suspected of containing the target polynucleotide is contacted with a polycationic multichromophore and a sensor polynucleotide complementary to the target polynucleotide
09/18/2007CA2348948C .beta.-l-2'-deoxy-nucleosides for the treatment of hiv infection
09/18/2007CA2308677C 4'-c-ethynyl purine nucleoside compounds
09/18/2007CA2308192C 4'-c-ethynyl pyrimidine nucleoside compounds
09/18/2007CA2167361C 2,2-difluoro-3-carbamoyl ribose sulfonate compounds and process for the preparation of beta nucleosides
09/13/2007WO2007102581A1 2'-hydroxyl-modified ribonucleoside derivative
09/13/2007WO2007085485A3 Lna modified phosphorothiolated oligonucleotides
09/13/2007WO2007039413A3 Selective o-acylation of nucleosides
09/13/2007WO2007014305A3 Assays for resistance to echinocandin-class drugs
09/13/2007US20070213294 Methods for modulating the axonal growth of central nervous system neurons
09/13/2007US20070213279 O6-alkylguanine-dna alkyltransferase inactivators and beta-glucuronidase cleavable prodrugs
09/12/2007EP1831238A2 Fluorous oligonucleotide reagents and affinity purification of oligonucleotides
09/12/2007EP1831237A1 Amide prodrug of gemcitabine, compositions and use thereof
09/12/2007EP1831236A1 Method for the preparation of 2'-deoxy-2',2'-difluorocytidine
09/12/2007EP1086251B1 Compounds and methods for detecting biomolecules
09/12/2007CN101033242A Antenna system for a level measurement apparatus
09/11/2007US7268119 Tricyclic nucleosides or nucleotides as therapeutic agents
09/11/2007CA2344643C Nucleotide compounds including a rigid linker
09/11/2007CA2193967C Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
09/07/2007WO2007099652A1 Pharmaceutical composition for treatment of blood clotting disorder
09/07/2007WO2007099389A1 A new improved process for the preparation of stavudine form i
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 201